Mallinckrodt plc Buyback
OLI recorded this information on 3/1/2017
Company: |
Mallinckrodt plc |
Buyback: |
MNK buyback |
$Amount Authorized: |
$1,000,000,000 |
Buyback Details: |
Mallinckrodt's Board of Directors authorized an incremental $1.0 billion repurchase of ordinary shares, reflecting the company's ongoing strong performance and future prospects. This authorization is in addition to prior authorizations approved by the Board, provides significant additional capacity to acquire shares within the company's capital allocation framework, and recognizes the company's commitments to all stakeholders. The share repurchase program is open-ended in time. |
Mallinckrodt develops, manufactures, and markets pharmaceutical products and diagnostic imaging agents. Co. focuses on the manufacturing of pain management medications. Co provides its products to several wholesalers and retail drug store chains.
Open the MNK Page at The Online Investor »
Open the MNK Page at The Online Investor (in a new window) »